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Objective: To determine the prevalence of medicine consumption among Spanish university students 
and its association with alcohol, tobacco and cannabis consumption. Method:  We carried out a 
cohort study among Spanish university students (n = 2,700). Consumption of medicines during the 
previous 15 days, risky alcohol use, and tobacco and cannabis consumption were measured using 
questionnaire. Logistic regression models were generated using consumption of medicines as 
dependent variables at the beginning of the study and for a 2-year follow-up. Results: A multivariate 
logistic regression model showed at the beginning of the study that being female (OR = 1.71), living 
away from home (OR = 1.35) and being a smoker (OR = 1.40) are associated with consumption of 
medicines. Furthermore, the model shows a significant interaction between risky alcohol use and 
cannabis consumption (OR = 2.00). The 2-year follow-up shows that only being female (OR = 1.44) 
and risky alcohol use (OR = 1.36) are associated with the considered dependent variable. 
Conclusions: Our results reveal a very high intake of medicines among university students; most of 
them are without a medical prescription. Probably, this consumption of medicines is another form of 
poly-consumption of drugs. 
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Over recent years, various epidemiological studies carried out not only on the general population 
(Sung et al., 2005; Carrasco-Garrido et al., 2008; Figueiras et al., 2000) but also on university 
populations (Cabrita et al., 2002; Boyd et al., 2007; McCabe et al., 2005, 2006a, b, c) have shown that 
medicine consumption by the young constitutes a public health problem. Indeed, the non-medical use 
of prescription pain medication among students has been increasing (McCabe et al., 2007). 
In Spain, several studies have shown a high consumption of medicines without prescription among 
young people (Carrasco-Garrido et al., 2008; Figueiras et al., 2000; Cabrita et al., 2002). Additionally, 
cross-sectional studies have revealed an association between the consumption of medicines, with and 
without prescription, and consumption of alcohol and tobacco (Carrasco-Garrido et al., 2008). No data 
is available about the association of cannabis. 
The factors which are associated to these practices have also been tackled, and the literature reveals 
that not only an individual’s characteristics (Carrasco-Garrido et al., 2008; Figueiras et al., 2000; 
Cabrita et al., 2002), but also the characteristics of his/her education centres (Boyd et al., 2007; 
McCabe et al., 2005, 2006a, b, c) are associated with consumption of medicines. 
Notwithstanding, the results of these studies lack external value, and therefore it is difficult to 
extrapolate them to our environment, given that the access to medicines is significantly different in 
different countries (Caamaño-Isorna et al., 2004; Caamaño et al., 2000). In Spain, to date there are no 
longitudinal studies that have looked into the association between consumption of medicines and the 
consumption of alcohol, tobacco and cannabis. 
The aim of this study is to determine the prevalence of medicine consumption among Spanish 
university students and its association with that of alcohol, tobacco and cannabis. 
 
Methods 
Design, population and sample 
A cohort study was carried out to determine the prevalence of medicine consumption among Spanish 
university students and its association with the consumption of alcohol, tobacco and cannabis. The 
study population included the first year students (18–19 years old) studying at the University of 
Santiago de Compostela (n = 2,700). Initial data collection was carried out by means of a 
questionnaire completed by students in the classroom (October 2005 to February 2006). The subjects 
were analysed again for a 2-year follow-up (October 2007 to February 2008).  
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Data collection procedures 
The consumption of medicines was measured using a questionnaire. The subjects were asked about 
their consumption of different medicines, with and without prescription, during the previous 15 days 
using the Spanish National Health Survey questions regarding this topic (INE, 2003). The 
questionnaire was anonymous, and the research group assured the participants that the data from the 
questionnaires would only be used for this study. 
Alcohol use was measured using the Galician validated version of the AUDIT (Saunders et al., 1993; 
Varela et al., 2005). In this version, for a screening of risky alcohol use, the cut-off value is 5 for men 
and 4 for women. 
At the same time as the AUDIT, we used another questionnaire that asked about tobacco and cannabis 
use. Specifically, we asked about tobacco and cannabis use not only when going out, but also in other 
situations. The subjects could choose one of the four answers: never, sometimes, often and always. 
Data collection procedures have been described in detail in previous articles (Caamaño-Isorna et al., 
2008; Mota et al., 2010). 
 
Definition of variables 
(1) Consumption of medicines: consumption of each medicine during the previous 15 days (yes = 1/no 
= 0). (2) Consumption of medicines with prescription: consumption of each medicine with 
prescription during the previous 15 days (yes = 1/no = 0). (3) Consumption of medicines without 
prescription: consumption of each medicine without prescription during the previous 15 days (yes = 
1/ no = 0). (4) Risky alcohol use: dichotomous variable. A cut-off value was established according to 
gender: >4 for women; and >5 for men. (5) Tobacco consumption and (6) cannabis consumption. 
These last two dichotomous variables were generated using the following question: ‘‘How often do 
you consume tobacco/cannabis when you go out or in any situation?’’ which was coded as follows: 
never = 0, sometimes = 1, often = 1 and always = 1. Moreover, several socio-demographic variables 
were considered such as gender, place of residence, and maternal educational level. 
 
Statistical analysis 
A statistical analysis was carried out using the SPSS 15.0 software package. Logistic regression was 
used to estimate odds ratios (OR) with a confidence interval of 95% for two dichotomous dependent 
variables: (1) consumption of medicines during the previous 15 days at the beginning of the study, 
and (2) consumption of medicines during the previous 15 days for the 2-year follow-up. Maximal 
models were generated including all theoretical independent variables. From these maximal models, 
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final models were generated. The final models included all significant variables and also no 
significant variables when their exclusion changed the OR of other variables by more than 10%. 
 
Results 
The response rate at the beginning of the study among students who were in class on the survey day 
was 99%. For the 2-year follow-up, participation rate was 64%. Table 1 shows the characteristics of 
the initial study sample and of the follow-up sample. There are no significant differences between 




The prevalence of risky alcohol use, tobacco consumption, and cannabis consumption at the 
beginning of the study and for the 2-year follow-up for the follow-up sample are shown in Table 1. 
The prevalence of risky alcohol use shows a significant increase of 36.1 versus 54.6%. Proportion of 
tobacco and cannabis users does not show differences between both the periods. 
Table 2 shows the proportion of students who have consumed medicines during the previous 15 days. 
The prevalence for total, with prescription, and without prescription consumption of medicines does 
not show differences between the initial study and the 2-year follow-up. Significant differences in 
medication consumption are only observed among medication for colds (33.9% for the initial study 




Table 3 presents the proportions of medicine consumption during the previous 15 days in relation to 
cannabis, tobacco and alcohol use at the beginning of the study and for the 2-year follow-up. The 
prevalence of consumption of medicines without prescription among cannabis, tobacco and alcohol 
users is greater than among non-users. However, for the 2-year follow-up this prevalence is only 
significant among cannabis users and cannabis non-users. In relation to the consumption of medicines 
with prescription, there are no significant differences between consumers and non-consumers, neither 
at the beginning of the study nor for the 2-year follow-up. 
 





Finally, Table 4 shows univariate and multivariate ORs for dependent dichotomous variables at the 
beginning of the study and for the 2-year follow-up. For the initial study, the multivariate logistic 
regression model showed that being female, living away from home, and being a smoker are 
associated with the consumption of medicines during the previous 15 days. Furthermore, the model 
shows a significant interaction between risky alcohol use and cannabis consumption. For the 2-year 







The proportion of subjects that have consumed medicines without prescription at the beginning of the 
study and for the 2-year follow-up is the same, and this proportion is significantly higher than that 
revealed by the Spanish National Health Surveys (Sung et al., 2005; Carrasco-Garrido et al., 2008; 
Figueiras et al., 2000). 
According to Carrasco-Garrido et al. (2008), the prevalence of self-medication among young people 
between the ages of 16–24 in the Spanish National Health Surveys was 20.85%, and among university 
students, it was 23.27%. 
The reason for this lower prevalence may be due to the period in which the data was collected: 
October to February versus January to December (INE, 2003). On the other hand, the short age range 
of our work deals with late adolescence, a period that is still related to high engagement in risk-taking 
behaviour (Spear, 2000), which may facilitate the consumption of medication without control. In 
general, the ease with which medicines are dispensed without prescription in Spain (Caamaño-Isorna 
et al., 2004) may explain part of this high prevalence of self-medication (Caamaño et al., 2000). 
In the so far consumption of medication, our results are similar to those provided by Cabrita et al. 
(2002) for Portuguese university students. 
In our study, significant differences between the consumption of medication for colds and of 
antibiotics have been found between the initial study and the 2-year follow-up. These differences are 
probably due to a lower incidence of the symptomatologies for which they are indicated. On the 
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contrary, the greater proportion of female students who consume contraceptives in the 2-year follow-
up would probably be an effect of the cohort’s age increase. This proportion is similar to that revealed 
by the Spanish National Health Surveys (Carrasco-Garrido et al., 2008). 
In relation to the association between the consumption of medicines and the use of cannabis, tobacco 
and alcohol, the results demonstrate that the consumption of medicines without prescription among 
cannabis, tobacco and alcohol users is greater than among non-users. These results are consistent with 
those revealed by different studies (Sung et al., 2005; McCabe et al., 2005, 2006c). Several studies 
have associated increased self-medication in young people as a greater need for self-affirmation and 
personal autonomy (Caamaño et al., 2000). Probably are the same reasons that could explain part of 
the largest consumer of drugs in users of tobacco, alcohol and cannabis. The greater accessibility to 
drugs in recent years makes this self-medication (Hemwall, 2010). 
However, after 2 years, cannabis, but neither alcohol nor tobacco, still presents as associated to 
medicine consumption without prescription. This data may suggest that the characteristics of cannabis 
users could be different from the characteristics of alcohol or tobacco users. 
There has been much controversy as to whether the consumption of medication should be considered 
a consequence of the consumption of tobacco, alcohol and cannabis, even though today the majority 
of authors agree that the consumption of medicines is another form of polyconsumption of drugs 
(McCabe et al., 2006b). It has been demonstrated that the reinforcing and pathological effects of 
ethanol consumption might be mediated through the endogenous cannabinoid system (see Hungund 
and Basavarajappa, 2004, for review). The CB1 receptor seems to play a critical role in clinically 
important aspects of alcohol dependence. In animal models, alcohol preference and self-
administration can be modulated with CB1 receptor agonists and antagonists. Furthermore, the stress 
(a relevant environmental factor in the vulnerability to alcohol) had no affect on alcohol preference in 
cannabinoid CB1 receptor-deficient mice (Racz et al., 2003). This commune neurophysiologic basis 
of evidence has prompted suggestion that alcohol/cannabis use may have pharmacological effects on 
brain function that increase the likelihood of using other drugs (Hall and Lynskey, 2005). 
Finally, multivariate logistic regression models show that being female and living away from home 
also represents risk factors for the consumption of medicines. With regard to gender, the prevalence of 
consumption of medicines among females is higher. These results are consistent with those put 
forward by various studies (Sung et al., 2005; Figueiras et al., 2000; Cabrita et al., 2002; Boyd et al., 
2007). The greater consumption of medication for menstrual symptoms may explain, at least partially, 
this higher prevalence (Obermeyer et al., 2004). 
With regard to the students’ place of residence, it is likely that the greater degree of freedom afforded 
by living away from the family environment during the first year of university is associated with a less 
orderly lifestyle and brings about a greater need for medicines for minor symptoms. Moreover, this 
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interpretation is congruent with the disappearance of that association in the 2-year follow-up. Studies 
that have been carried out in other environments have also revealed an association between place of 
residence and the consumption of medication (McCabe et al., 2005, 2006a), although important 
cultural differences make the data comparison somewhat difficult. 
There are two possible limitations in our study: (1) Selection bias, because of the loss of subjects in 
the follow-up. However, the absence of significant differences between the initial sample and the 
follow-up sample (Table 1) suggests an absence of this bias. (2) Given that the questions about the use 
of tobacco and cannabis are not specifically validated, the use of these may have not been correctly 
measured. Finally, consumption of medicines, tobacco and cannabis were self reported, which could 
underestimate these variables. 
Our results reveal a very high intake of medicines among university students, most of them without a 
medical prescription. The consumption of medicines shows a significant association with 
consumption of alcohol, tobacco and cannabis, and it has a greater prevalence among women and 
those students who are living away from the parents’ home. Probably, this consumption of medicines 
is another form of poly-consumption of drugs. 
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Table 1. Characteristics of the subjects: Initial study sample and follow-up sample 
 
 Percentage (95% confidence interval) 
 Sample (n1 = 1,369) Follow-up sample (n2 = 877) 
 Initial study Initial study 2-year follow-up 
Age (mean) 18.5 (18.4–18.6) 18.4 (18.3–18.5) 20.3 (20.1–20.6) 
Female 72.5 (70.1–75.0) 76.3 (73.4–79.2) 76.3 (73.4–79.2) 
Residence: Outside the parents’ home 74.1 (71.8–76.5) 75.6 (72.7–78.5) 76.4 (73.5–79.3) 
Maternal educational level    
 Primary school 38.6 (36.0–41.2) 29.3 (26.2–32.4)  
 High school 31.4 (29.0–33.9) 41.7 (38.4–45.1)  
 University studies 28.4 (26.0–30.8) 27.7 (24.7–30.7)  
Risky alcohol use 37.1 (34.5–39.7) 36.1 (32.9–39.4) 54.6 (51.3–57.9) 
Tobacco consumption 30.1 (27.6–32.6) 29.2 (26.1–32.3) 29.4 (26.7–32.1) 
Cannabis consumption 20.8 (18.6–23.0) 21.0 (18.2–23.7) 17.0 (14.4–19.5) 
Maternal educational level was not measured in the follow-up questionnaire 
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Table 2.  Proportions of subjects that have consumed medicines during the previous 15 days 
 
 Percentages (95% confidence interval) 
 With prescription Without prescription Total 
 Initial study 2-year follow-up  Initial study 2-year follow-up Initial study 2-year follow-up 
Medication for colds, flu 12.4 (10.6–14.2) 4.7 (3.2–6.1)* 21.7 (19.5–23.9) 15.2 (12.7–17.6)* 33.9 (31.3–36.4)  19.5 (16.8–22.2)* 
Medication for pain or fever  7.9 (6.4–9.3) 6.3 (4.6–7.9) 15.9 (13.9–17.8)  19.0 (16.4–21.7) 23.6 (21.3–25.9) 25.2 (22.3–28.1) 
Contraceptivesa 12.4 (10.3–14.5)  25.9 (22.5–29.3)* 3.2 (2.1–4.4) 4.6 (3.0–6.3) 15.6 (13.5–17.9)  30.5 (26.9–34.6)* 
Antibiotics 11.5 (9.8–13.3) 5.7 (4.1–7.3)* 3.1 (2.2–4.1) 1.4 (0.5–2.1)* 14.6 (12.7–16.5) 7.1 (5.3–8.8)* 
Vitamins, minerals, tonics 5.3 (4.1–6.6) 2.6 (1.52–4.1) 6.8 (5.4–8.2) 8.1 (6.2–10.0) 12.1 (10.3–13.8) 10.7 (8.3–12.8) 
Medication for allergies 7.7 (6.2–9.1) 9.4 (7.4–11.3) 1.2 (0.6–1.9) 1.0 (0.3–1.7) 8.9 (7.3–10.5) 10.4 (8.0–12.5) 
Anxiolytics, sedatives 1.9 (1.1–2.6) 1.7 (0.8–2.6) 3.0 (2.1–3.9) 2.6 (1.5–3.7) 4.9 (3.7–6.1) 4.3 (2.9–5.7) 
Antidepressants, stimulants 0.9 (0.3–1.4) 2.4 (1.3–3.4) 0.5 (0.1–0.9) 0.3 (0.07–1.0) 1.4 (0.7–2.0) 2.7 (1.3–3.9) 
Any medicationb 31.2 (28.7–33.7) 27.7 (24.7–30.7) 35.4 (32.9–38.0) 32.9 (29.8–36.1) 57.8 (55.1–60.4) 52.2 (51.9–58.6) 
a Out of the total number of female students 
b Contraceptives excluded 
* Comparison of two proportions, p \ 0.05 
 
  
Post-print (final draft post-refereeing)
 
Table 3. Percentages of medicine consumption during the previous 15 days in relation to the use of cannabis, tobacco and alcohol for the initial study and for the 2-year 
follow-up 
 
 Cannabis Tobacco Alcohol Cannabis, tobacco and alcohol 
 No Yes p value No Yes p value No risk Risk p value No Yes p value 
Initial study             
    Medication for colds, flu 32.0 41.0 0.004 31.8 38.8 0.011 32.3 37.2 0.080 30.9 45.3 0.001 
    Medication for pain or fever 22.0 29.5 0.009 22.2 26.9 0.050 22.0 26.4 0.092 21.4 32.4 0.005 
    Antibiotics 13.4 19.3 0.012 13.9 16.3 0.256 13.1 17.3 0.042 12.1 19.4 0.021 
    Contraceptivesa 14.1 22.2 0.007 14.5 18.2 0.137 14.1 18.1 0.090 13.1 21.4 0.031 
    Vitamins, minerals, tonics 10.6 17.5 0.001 10.5 15.5 0.009 10.1 15.6 0.003 9.9 21.6 0.001 
    Anxiolytics, sedatives 4.2 7.4 0.030 4.1 6.8 0.032 4.0 6.5 0.037 4.0 9.4 0.009 
    Antidepressants, stimulants 1.0 2.8 0.021 1.2 1.7 0.518 1.3 1.6 0.661 0.7 0.7 0.947 
    All medicines 55.5 66.3 0.001 54.2 66.0 <0.001 54.5 63.2 0.002 55.8 75.5 <0.001 
    All medicines without prescriptionb 32.8 45.3 <0.001 32.8 41.5 0.002 30.9 43.3 <0.001 33.3 54.7 <0.001 
    All medicines with prescriptionb 30.7 33.3 0.463 30.0 34.0 0.144 31.6 30.3 0.626 30.9 33.8 0.481 
2-year follow-up 
    Medication for colds, flu 19.1 21.5 0.504 19.7 18.8 0.805 17.4 21.3 0.152 19.2 22.7 0.469 
    Medication for pain or fever 24.0 30.9 0.079 23.9 30.6 0.069 22.9 27.2 0.146 24.4 33.3 0.090 
    Antibiotics 7.6 4.7 0.215 7.2 6.5 0.734 7.5 6.7 0.676 7.2 5.3 0.540 
    Contraceptivesa 30.8 28.7 0.259 29.5 34.6 0.255 30.0 30.9 0.802 30.6 28.8 0.788 
    Vitamins, minerals, tonics 9.9 14.8 0.079 10.6 11.2 0.830 10.7 10.7 0.985 10.3 14.7 0.248 
    Anxiolytics, sedatives 4.1 5.4 0.495 3.7 7.1 0.050 3.7 4.8 0.421 4.2 5.3 0.656 
    Antidepressants, stimulants 2.6 3.4 0.611 2.7 2.9 0.856 3.2 2.3 0.406 2.9 1.3 0.436 
    All medicinesb 52.1 59.1 0.119 52.1 58.2 0.147 49.5 56.4 0.041 52.9 57.3 0.459 
    All medicines without prescriptionb 31.5 40.3 0.037 32.5 34.7 0.588 30.1 35.4 0.098 32.2 41.3 0.106 
    All medicines with prescriptionb 28.0 26.2 0.646 27.0 30.6 0.350 26.9 27.6 0.926 27.9 25.3 0.631 
 
a Out of the total number of female students 
b Contraceptives excluded 
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Table 4. Influence of subjects’ characteristics on consumption of medicines for the initial study and for the 2-year follow-up  
 
 Consumption of medicines during the previous 15 days [OR (95% Confidence Interval)]a 
  Initial study  2-year follow-up  
 Multivariateb  Univariate Multivariateb Univariate 
Gender     
    Male 1c 1 1 1 
    Female 1.70 (1.33–2.16) 1.71 (1.33–2.19) 1.39 (1.02–1.90) 1.44 (1.05–1.97)  
Residence     
    At parents’ home 1 1 1  
    Outside the parents’ home 1.44 (1.13–1.84) 1.35 (1.05–1.64) 1.31 (0.96–1.81)   
Cannabis consumption     
    No 1 1 1  
    Yes 1.58 (1.20–2.07) 0.91 (0.58–1.43) 1.32 (0.93–1.90)   
Risky alcohol use     
    No 1 1 1 1 
    Yes 1.43 (1.14–1.80) 1.00 (0.76–1.31) 1.32 (1.02–1.72) 1.36 (1.04–1.78)  
Tobacco consumption     
    No 1 1 1  
    Yes 1.64 (1.29–2.09) 1.40 (1.06–1.84) 1.28 (0.92–1.80)   
Risky alcohol use x Cannabis     
    No 1    
    Yes 2.00 (1.11–3.60)    
 
a Contraceptives excluded 
b Adjusted for the other independent variables included in the column 
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